The Efficacy of Allo-HSCT in ND HR-CBF-AML — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Efficacy of Allo-HSCT in ND HR-CBF-AML — Stella

Home/Acute Myeloid Leukemia/

View on ClinicalTrials.gov

Recruiting

Back to Acute Myeloid Leukemia trials

Trial locations(1 site)

China

Ruijin Hospital Affiliated to Shanghai Jiaotong University School Of Medicine, Shanghai, Shanghai Municipality

Key details

Sponsor

Ruijin Hospital

Enrollment target

~90 participants

Started

September 2024

Primary completion

September 2026

Age range

18 Years – 65 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.